ciclopirox and Complications of Diabetes Mellitus studies

ciclopirox and Complications of Diabetes Mellitus

Research Excerpts

Excerpt	Relevance	Reference
"This multicenter, open-label, uncontrolled, noncomparative, observational, postmarketing study assessed the efficacy and safety of ciclopirox nail lacquer solution 8% in 3666 patients for the treatment of onychomycosis."	9.09	A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. ( Nietsch, KH; Seebacher, C; Ulbricht, HM, 2001)
"This multicenter, open-label, uncontrolled, noncomparative, observational, postmarketing study assessed the efficacy and safety of ciclopirox nail lacquer solution 8% in 3666 patients for the treatment of onychomycosis."	5.09	A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. ( Nietsch, KH; Seebacher, C; Ulbricht, HM, 2001)
"Terbinafine is an excellent choice in diabetics due to its low risk of drug-drug interaction and proven efficacy against the typical pathogens that cause onychomycosis."	4.85	Onychomycosis and diabetes. ( Cantrell, W; Cathcart, S; Elewski, Be, 2009)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

2 (100.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Cathcart, S	1
Cantrell, W	1
Elewski, Be	1
Seebacher, C	1
Nietsch, KH	1
Ulbricht, HM	1

Studies

Cathcart, S

Cantrell, W

Elewski, Be

Seebacher, C

Nietsch, KH

Ulbricht, HM

Reviews

1 review available for ciclopirox and Complications of Diabetes Mellitus

Article	Year
Onychomycosis and diabetes. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:10 Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines;	2009

Article

Year

Onychomycosis and diabetes.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:10

Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines;

2009

Trials

1 trial available for ciclopirox and Complications of Diabetes Mellitus

Article	Year
A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. Cutis, 2001, Volume: 68, Issue:2 Suppl Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ciclopirox; Diabetes Com	2001

Article

Year

A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes.

Cutis, 2001, Volume: 68, Issue:2 Suppl

Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ciclopirox; Diabetes Com

2001